Literature DB >> 1262462

Mixed lymphocyte cultures in rheumatoid arthritis.

P Stastny.   

Abstract

Random one-way microtiter mixed lymphocyte cultures between 43 rheumatoid arthritis (RA) patients and 45 controls consisting of 26 normal subjects and 19 miscellaneous non-RA patients were performed and results were evaluated as relative responses. Low responses (consisting of relative response less than 38%) were found in 31 out of 43 RA patients in cultures against eight of the RA stimulators. The remaining 35 RA stimulators tested yielded only normal mixed lymphocyte culture reactions. The same RA patients used as responders never produced low responses when stimulated by non-RA lymphocytes. But six of the control subjects gave low responses to two RA stimulators. The low responses did not appear to correlate with intake of aspirin, prednisolone, or gold salts, nor could they be reproduced by addition of RA serum of 7S or 19S fractions thereof containing either polyclonal or monoclonal rheumatoid factors. Short-term culture and washing before mixing with the allogeneic cells did not change the low responses suggesting that in vivo bound autoantibodies against lymphocyte receptors were not involved. Study of the inheritance of HLA and mixed lymphocyte culture determinants in the family of patient A. C. who most frequently elicited low responses indicated she was homozygous for a lymphocyte-defined determinant which has been called R. The low responses to A. C. could be interpreted as typing responses based on sharing of the same or of a similar lymphocyte-defined determinant. This gene appears to be increased in patients with RA with respect to non-RA controls and may reflect an association of genes within the HLA chromosomal region leading to predisposition for the development of RA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262462      PMCID: PMC436767          DOI: 10.1172/JCI108382

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families.

Authors:  S M Fu; R Stern; H G Kunkel; B Dupont; J A Hansen; N K Day; R A Good; C Jersild; M Fotino
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

2.  Effect of steroids on lysosomes.

Authors:  I M Goldstein
Journal:  Transplant Proc       Date:  1975-03       Impact factor: 1.066

3.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

4.  Tissue typing antisera from immunization by pregnancy.

Authors:  P Stastny
Journal:  Tissue Antigens       Date:  1972

5.  HL-A antigens and multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

6.  Multiple sclerosis: association with HL-A3.

Authors:  S Naito; N Namerow; M R Mickey; P I Terasaki
Journal:  Tissue Antigens       Date:  1972

7.  Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor.

Authors:  R J Hartzman; M L Bach; F H Bach; G B Thurman; K W Sell
Journal:  Cell Immunol       Date:  1972-06       Impact factor: 4.868

8.  Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis.

Authors:  G P Astorga; R C Williams
Journal:  Arthritis Rheum       Date:  1969-12

9.  The genetics of rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Clin Exp Immunol       Date:  1967-12       Impact factor: 4.330

10.  Suppression of lymphocyte transformation after aspirin ingestion.

Authors:  J E Crout; B Hepburn; R E Ritts
Journal:  N Engl J Med       Date:  1975-01-30       Impact factor: 91.245

View more
  90 in total

1.  HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Hermann; J Tuokko; R Luukkainen; M Hakala; P Hannonen; M Korpela; U Yli-Kerttula; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

2.  Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.

Authors:  I O Auer; C Buschmann; E Ziemer
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

Review 3.  Evolution of HLA class-II genes and haplotypes.

Authors:  J Silver
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice.

Authors:  Alexei von Delwig; Daniel M Altmann; Fraser G Charlton; Norman McKie; John D Isaacs; Rikard Holmdahl; John H Robinson
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

5.  Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Luukkainen; M Hakala; U Yli-Kerttula; P Hannonen; J Tuokko; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 6.  Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Atsushi Hashimoto; Shigeto Tohma
Journal:  J Hum Genet       Date:  2015-04-23       Impact factor: 3.172

Review 7.  Molecular mechanisms involved in the association of HLA-DR4 and rheumatoid arthritis.

Authors:  I Auger; E Toussirot; J Roudier
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

8.  HLA-DRB1 frequency in patients with familial and sporadic rheumatoid arthritis in north east of Iran.

Authors:  Massoud Saghafi; Najmeh Nohesara; Houshang Rafatpanah; Jaleh Shariati; Mohamad Taghi Shakeri
Journal:  Clin Rheumatol       Date:  2014-04-24       Impact factor: 2.980

Review 9.  The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.

Authors:  Marieke Bax; Tom W J Huizinga; René E M Toes
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

Review 10.  The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping.

Authors:  Stephen Eyre; Gisela Orozco; Jane Worthington
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.